Risk Factors, Interventions and Therapeutic Agents in the Prevention of Atherosclerosis-Related Ischaemic Diseases
- 1 January 1991
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 42 (5) , 22-38
- https://doi.org/10.2165/00003495-199100425-00006
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasPublished by Elsevier ,1990
- Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial InfarctionNew England Journal of Medicine, 1989
- The Effect of Diltiazem on Mortality and Reinfarction after Myocardial InfarctionNew England Journal of Medicine, 1988
- Costs and Effectiveness of Routine Therapy with Long-Term Beta-Adrenergic Antagonists after Acute Myocardial InfarctionNew England Journal of Medicine, 1988
- DipyridamoleNew England Journal of Medicine, 1987
- Current Issues in Thrombosis Prevention with Antiplatelet DrugsDrugs, 1986
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Prevention of Thrombosis in Patients on Hemodialysis by Low-Dose AspirinNew England Journal of Medicine, 1979
- Evidence Favoring the Use of Anticoagulants in the Hospital Phase of Acute Myocardial InfarctionNew England Journal of Medicine, 1977